ADC Therapeutics SA
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
- Pharmaceuticals
Other Names/Subsidiaries
- ADC Therapeutics Sarl
- ADC Therapeutics S.A.
Latest on ADC Therapeutics SA
BioNTech’s acquisition of fellow German mRNA company CureVac underscored a trend in biotech: many companies form around new technologies, but not all succeed. A Very German Transaction BioNTech’s acq
Insmed capitalized on the company’s better-than-expected Phase IIb clinical trial readout for treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension (PAH), which sent its s
Merck & Co.’s initial Phase II/III waveLINE-003 data for zilovertamab vedotin (zilo-V) in diffuse large B-cell lymphoma (DLBCL) at the American Society of Clinical Oncology meeting in Chicago rais
These are tough times for start-ups to raise cash on this side of the Atlantic but the money is there if you are developing a novel class of payloads in the hot space of antibody-drug conjugates (ADC)